| Similar Articles |
|---|
 |
The Motley Fool
June 28, 2010
Luke Timmerman |
Orexigen Drug Shows Potential as "Two-Fer" Against Obesity and Diabetes Orexigen's latest drug aims at treating both diabetes and obesity.   |
American Family Physician
June 15, 2004
Mark H. Ebell |
Point-of-Care Guides Clinical Question: What is the best way to manage uncomplicated acute otitis media (AOM) in otherwise healthy children? The answer follows. |
American Family Physician
June 15, 2004
Genevieve Ressel |
Newsletter Robert Graham Center Releases Study of Medical Errors Based on Malpractice Cases... Guideline on Otitis Media with Effusion Urges Watchful Waiting... CDC Launches Autism Awareness Campaign... etc. |
American Family Physician
March 15, 2004 |
Newsletter A recent report by the Institute of Medicine (IOM) urges educators and other groups to focus more attention on strategies for reducing barriers that deny minorities access to careers in the health professions. |
American Family Physician
September 15, 2006
Wong et al. |
Guidelines for the Use of Antibiotics in Acute Upper Respiratory Tract Infections To help physicians with the appropriate use of antibiotics in children and adults with upper respiratory tract infection, a multidisciplinary team evaluated existing guidelines and summarized key practice points. |
Nursing Management
January 2012
Lawrence et al. |
Type 2 Diabetes: Growing to Epic Proportions Affecting all age groups and all aspects of a person's life, diabetes is a major public health issue worldwide, requiring lifelong behavioral and lifestyle changes and support. |
Wired
October 2006
Thomas Goetz |
The Thin Pill 75 million Americans may have something called metabolic syndrome. How Big Pharma turned obesity into a disease - then invented the drugs to cure it. |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Battle of the Bulge: Biotech Takes on Obesity and Diabetes Will recent advances in pharmaceutical research revolutionize the weight loss industry? It's still early days, but here are some of the stocks to watch. |
Managed Care
December 2004
Jack McCain |
The Weight Debate, Continued This article presents the views of people who indulge in what many regard as health care heresy. They challenge the conventional wisdom that millions of Americans need to lose tons of weight, fast, to stave off diabetes, heart disease, cancer. |
Nursing
September 2010
Margaret M. Bolton |
Sounding the alarm about metabolic syndrome Any health problem that affects a third of American adults is sure to impact your nursing practice. Metabolic syndrome, a growing and commonly silent condition, poses a significant public health crisis. |
The Motley Fool
December 31, 2010
Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
American Family Physician
June 1, 2001
James M. Lyznicki |
Obesity: Assessment and Management in Primary Care Obesity is a complex, multifactorial condition in which excess body fat may put a person at health risk. National data indicate that the prevalence of obesity in the United States is increasing in children and adults... |
American Family Physician
November 1, 2000
Monica Preboth |
Clinical Briefs Sports Specialization in Young Athletes... ADA Statement on Nutrition in Diabetes... Diagnostic Imaging to Detect Child Abuse... NIH/NIA Report on Alzheimer's Disease... CDC Report on U.S. Incidence of Measles in 1999... Managing Pain and Stress in the Neonate... |
American Family Physician
June 15, 2006
Liz Smith |
Newsletter Panel Advocates Changes in FDA Regulation of Dietary Supplements... Health Information Community Delivers First Recommendations... Medical Liability Reform Bill Fails to Reach Senate Floor... etc. |
American Family Physician
July 15, 2004
Genevieve Ressel |
Newsletter FDA Warns Against Using Domperidone to Increase Breast Milk Production... AAFP Members Visit Lawmakers in Washington, D.C... CDC Reports Data on Suicide Behaviors, Risk Factors, and Prevention... etc. |
The Motley Fool
July 16, 2010
Tom Hughes |
Lessons Learned About the Outlook for New Obesity Drug Approval The recent FDA advisory committee meeting on Vivus' weight loss pill proved to us, once again, how incredibly difficult it is to successfully develop and register new drugs for obesity. |
Science News
January 3, 2004
Kate Ramsayer |
Putting Labels on Nutrients Do those nutrition fact boxes on packaged foods supply the information that people really need? Two new reports suggest that they don't. |
The Motley Fool
November 24, 2010
Brian Orelli |
Profit From the United States of Diabetes Half the country could have an early form by 2020. |
Food Processing
April 2006
Leslie Krasny |
Regulatory Issues: Marketing Products Using the Dietary Guidelines Companies must ensure that any marketing use of the Dietary Guidelines for Americans is truthful and not misleading within the total context. |
American Family Physician
March 15, 2001
Goutham Rao |
Insulin Resistance Syndrome Insulin resistance can be linked to diabetes, hypertension, dyslipidemia, cardiovascular disease and other abnormalities. Because resistance usually develops long before these diseases appear, identifying and treating insulin-resistant patients has potentially great preventive value... |
Food Processing
December 2007
Tevi Troy |
Expert Opinion: Wellness in Crisis Good health may be the most overlooked and under appreciated of life's blessings. |
American Family Physician
May 15, 2003
Matthew Neff |
Newsletter FDA, CDC Respond to Increasing Threat of SARS... HHS Releases HIPAA-Related Documents on Patient Privacy Standards... New Research Journal, Annals of Family Medicine, to Debut This Month... HHS Announces $15 Million Health Initiative Focused on Prevention |
The Motley Fool
June 3, 2011
Luke Timmerman |
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold The close attention paid to safety makes this drug difficult to get right. |
American Family Physician
April 15, 2004
Rao, Disraeli & Mcgregor |
Impaired Glucose Tolerance and Impaired Fasting Glucose Impaired glucose tolerance and impaired fasting glucose form an intermediate stage in the natural history of diabetes mellitus. |
BusinessWeek
September 1, 2009
Catherine Arnst |
Opportunities in the Obesity Epidemic Drugmakers are ratcheting up research into treatments for gout and other ills that plague the overweight. |
The Motley Fool
July 8, 2008
Brian Lawler |
Blockbuster Drugs Bound for Extinction? One of the biggest classes of prescription drugs, those for diabetes treatments, faces tougher FDA standards. |
The Motley Fool
June 25, 2010
Brian Orelli |
Mark Your Calendars: Obesity Drugs Take Center Stage Orexigen Therapeutics has been given an FDA advisory committee meeting date, completing the dates for the trio of obesity drugs up for review. |
American Journal of Nursing
June 2008
Hart et al. |
Acute Respiratory Infections and Antimicrobial Resistance It is important that nurses understand antimicrobial resistance and learn how to help patients, family members, and friends manage acute respiratory infections appropriately. |
The Motley Fool
June 29, 2010
Brian Orelli |
Diabetes Drug Development Pops and Drops When companies present at a major meeting, there's bound to be both. |
American Family Physician
September 15, 2006
Havas & Donner |
Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications. |
American Family Physician
July 15, 2003
Matthew Neff |
Newsletter CDC Web Page Provides Up-To-Date Information on Monkeypox... HHS Streamlines FDA Regulations for Generic Drug Approvals... AHRQ Releases Men's Health Brochure for Screening Tests and Staying Healthy... Coalition Announces Agenda for Addressing the Issue of Low Health Literacy... etc. |
BusinessWeek
December 22, 2003
Arlene Weintraub |
Big Pharma Looks Beyond Insulin Researchers may be on the verge of major new treatments for diabetes and obesity. |
AskMen.com
Alex Santoso |
What You Should Know About Diabetes Not many men understand what diabetes is, why it's very bad for them (it is one of the leading causes of impotence), what they can do to avoid getting it or how to treat it. |
The Motley Fool
September 2, 2010
Luke Timmerman |
Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb San Diego-based Orexigen Therapeutics has found a partner to help it compete in the growing market for drugs to combat obesity, Japan-based Takeda Pharmaceutical. |
Chemistry World
July 18, 2012
Andrew Turley |
Obesity drug approved in US US regulators have approved a new obesity treatment. Qsymia (phentermine, topiramate) tablets have been approved for overweight adults as part of a regimen that includes a low calorie diet and exercise. |
Managed Care
May 2006
Fadia T. Shaya & Deshpande |
New Treatment Approaches To Diabetes The goal of diabetes management is maintaining glycemic control while targeting quality of life improvements. |
Pharmaceutical Executive
June 1, 2014
Jill Wechsler |
Compassionate Use Requests Complicate Drug Development Pharma, HCPs, and regulators walk tightrope in addressing early-access push while supporting biomedical R&D. |
Pharmaceutical Executive
March 1, 2013
Ben Comer |
Brand of the Year: Januvia When Merck's Januvia received its first regulatory approval, in Mexico in 2006, no one predicted its long-term success. In 2012, the company's diabetes franchise became the highest-selling product family in Merck's 122-year history. |
American Family Physician
September 15, 2000
Monica Preboth |
Clinical Briefs AAP Policy Statement on Childhood Bereavement... FDA Approval of Rivastigmine Tartrate... Use of Activella to Prevent Osteoporosis... Personal Watercraft Use by Young Persons... New AHA Web Site to Improve Patient Compliance... Services for Children with Special Needs... |
The Motley Fool
June 3, 2011
Brian Orelli |
FDA Bullies Obesity Drugmakers It's been clear for some time that the Food and Drug Administration isn't particularly fond of obesity drugs. Now it's just being a bully. |
Pharmaceutical Executive
August 1, 2012
Jill Wechsler |
Fleshing Out FDASIA Medical apps, e-submissions, counterfeit drugs, and imports tucked into fairly "clean" user-fee renewal legislation. In late June leading legislators reached across party lines to quickly approve the Food and Drug Administration Safety and Innovation Act. |
American Family Physician
December 15, 2000
Monica Preboth |
Clinical Briefs AAP Statement on Suicide in Adolescents... Preventing Pregnancy Loss in Women with Diabetes... Climatic Heat Stress and Exercise in Children... etc. |
Nurse Practitioner
May 2008
Jarosz & Bellar |
Age-Appropriate Obesity Treatment Older adults who are obese must be assessed and treated for obesity within the context of aging. |
Pharmaceutical Executive
December 1, 2013 |
FDA Pursues Delicate Balancing Act The Agency struggles to ensure access to needed medicines while minimizing potential risks, writes Jill Wechsler. |
Pharmaceutical Executive
October 1, 2005 |
Changing Diabetes An interview with Novo Nordisk's president of U.S. operations Martin Soeters on how a nation that leads the world in diabetes research does such a poor job of treating it. Here, he offers some solutions. |
The Motley Fool
June 30, 2011
David Williamson |
Biotech Takes On the Next Big Problem The news coming out of this week's annual conference of the American Diabetes Association wasn't good. |
The Motley Fool
July 14, 2010
Luke Timmerman |
Vivus Faces Turning Point Tomorrow Thursday's the big day. All eyes will be on Vivus and the FDA's decision on their new obesity drug |
American Family Physician
March 15, 2001
Thomas Hooton & Stuart Levy |
Antimicrobial Resistance: A Plan of Action for Community Practice Antibiotic resistance was once confined primarily to hospitals but is becoming increasingly prevalent in family practice settings, making daily therapeutic decisions more challenging. |
American Family Physician
November 15, 2000 |
Clinical Briefs Reducing Falls Among Older Women... Physical Activity and Fitness in Schools... Exercise in the Patient with Diabetes Mellitus... Blueprint for Development of Tuberculosis Vaccine... Answers to This Issues' Clinical Quiz... |
American Family Physician
January 15, 2004
Koenigsberg et al. |
Facilitating Treatment Adherence with Lifestyle Changes in Diabetes Healthy eating and increased physical activity can prevent or delay diabetes and its complications. Techniques that facilitate adherence to these lifestyle changes can be adapted to primary care. |
